
Pediatrician

No OPD information available
Rheumatic Fever
Malaria
Strep Throat
Acute Pain
Adenoidectomy
Anemia
Anti-NMDA Receptor Encephalitis
Arthritis
Bullous Pemphigoid
Common Variable Immune Deficiency
Febrile Neutropenia
Glossitis
Hepatic Venoocclusive Disease with Immunodeficiency
Hypothermia
Infantile Neutropenia
Infantile Pyloric Stenosis
Necrotizing Enterocolitis
Premature Infant
Primary Lateral Sclerosis
Sepsis
Streptococcal Group A Infection
Sam Salman is a male healthcare provider who helps people with different health problems like Rheumatic Fever, Malaria, Strep Throat, and many others. He is skilled in treating various conditions such as Acute Pain, Anemia, Arthritis, and more. Sam Salman is known for his expertise in dealing with complex medical issues like Anti-NMDA Receptor Encephalitis, Glossitis, and Sepsis.
Patients trust Sam Salman because he communicates effectively and listens carefully to their concerns. He explains medical conditions in a way that is easy to understand, making patients feel comfortable and informed during their treatment. Sam Salman stays updated with the latest medical knowledge and research to provide the best care possible to his patients.
Sam Salman works closely with other medical professionals, collaborating on treatment plans and sharing knowledge to ensure the best outcomes for patients. His relationships with colleagues are built on mutual respect and a shared commitment to providing quality healthcare.
One of Sam Salman's notable publications is a study on a simplified amoxicillin regimen for neonates with infections, showing his dedication to improving treatment methods. He has also conducted clinical trials to assess the safety and tolerability of new medications in elderly subjects, demonstrating his commitment to advancing medical research.
Through his work, Sam Salman has positively impacted many patients' lives by providing effective treatments and compassionate care. His dedication to staying informed, collaborating with colleagues, and conducting research shows his commitment to improving healthcare and making a difference in the lives of those he treats.
Enrollment Status: Completed
Published: January 22, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 1
